Ms. Andi Leubitz joined Eloxx in August 2016 and is currently Executive Director of Clinical Operations and the Site Head for the Israel office. Ms. Leubitz brings more than 18 years of clinical operations experience in both the pharmaceutical and medical device industries.
Ms. Leubitz previously served as a core functional lead in clinical operations at Becton, Dickinson and Company, Teva Pharmaceuticals and VBL Therapeutics. She brings a wealth of knowledge across a broad range of focus areas, which include managing and monitoring clinical trials, contract and budget negotiation, clinical trial set up and execution, vendor oversight, site management, team management and she serves as a bridge between clinical operations and other business units at Eloxx.
Ms. Leubitz holds a Bachelor of Arts Degree in Communication and a Master’s degree in Clinical Research from The Ohio State University.